SEC Form 4 · accession 0001645627-17-000083
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 20, 2017
Accepted (ET)
Jun 21, 2017 · 3:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2017 | P | 1,000 | $0.05 | A | 21,270,349 | D | |
| Common Stock | Jun 20, 2017 | P | 1,000 | $0.0518 | A | 21,271,349 | D | |
| Common Stock | Jun 20, 2017 | P | 1,000 | $0.0516 | A | 21,272,349 | D | |
| Common Stock | Jun 20, 2017 | P | 1,000 | $0.051 | A | 21,273,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.048 | A | 21,275,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0478 | A | 21,277,349 | D | |
| Common Stock | Jun 20, 2017 | P | 1,000 | $0.0493 | A | 21,278,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0492 | A | 21,280,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0488 | A | 21,282,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0475 | A | 21,284,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0444 | A | 21,286,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0444 | A | 21,288,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0444 | A | 21,290,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0442 | A | 21,292,349 | D | |
| Common Stock | Jun 20, 2017 | P | 2,000 | $0.0444 | A | 21,294,349 | D |
Table II — derivative securities
No Table II lines on this filing.